Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier
Clinical trial NCT02581410 · COMPLETED
Trial details
- NCT number
- NCT02581410
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-15
- Primary completion
- 2016-08-30
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.